3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
28
Lymphoma, Follicular
17
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Mantle-Cell
6
Lymphoma
5
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma, B-Cell
3
Leukemia
3
Neoplasms
2
Bronchiolitis Obliterans Syndrome
2
Tumor Lysis Syndrome
1
Solid Tumors
1
Recurrence
1
Oncology Patients Receiving Chemotherapy
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphoid
1
Leukemia, Hairy Cell
1
Indolent Non-Hodgkin's Lymphoma
1
Chromosome 17 deletion
1
Carcinoma, Non-Small-Cell Lung
1
B-cell Malignancies
1
Anemia
1
Interventions
Radiotherapy
22
Fluorouracil
20
Oxaliplatin
19
Leucovorin
14
Cisplatin
14
Paclitaxel
10
Radiation
8
Irinotecan
8
Docetaxel
7
Capecitabine
7
Cetuximab
6
Carboplatin
6
pembrolizumab
5
Neoadjuvant Therapy
5
Trastuzumab
4
Taxes
4
Chemotherapy, Adjuvant
4
Panitumumab
3
Microarray Analysis
3
Immunohistochemistry
3
Folfox protocol
3
Epirubicin
3
Biopsy
3
tucatinib
2
Surgical Procedures, Operative
2
Reverse Transcriptase Polymerase Chain Reaction
2
Magnetic Resonance Spectroscopy
2
Gene Expression Profiling
2
Gefitinib
2
Everolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma Of Esophagus
×
obinutuzumab
×
Clear all
No trials found.